Related Experiment Video
Updated: May 31, 2025

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
FEV1/FEV6 Cutoff Points to Avoid False Negatives When Using Portable Devices, PICO-6® and COPD-6®, in COPD Detection
Miguel A Hernandez-Mezquita1,2,3, Idania De Los Santos-Ventura1, Vanesa Hidalgo-Sierra4
1Pneumology Department, Salamanca University Hospital, 37007 Salamanca, Spain.
Abstract:
Background: Chronic obstructive pulmonary disease (COPD) is a frequent but underdiagnosed disease, primarily due to the lack of access to forced spirometry (FS) in primary care. Portable, easy-to-use expiratory flow meters like Piko-6® and COPD-6® that measure FEV1, FEV6, and FEV1/FEV6 ratio provide an alternative. Given that Piko-6® and COPD-6® devices measure FEV6 but not FVC, the aim of the study is to determine the optimal cutoff value for the FEV1/FEV6 ratio of each device to avoid false negatives when these devices are used for COPD screening in primary care (PC). Methods: A total of 664 patients of 35 years of age or older with a cumulative tobacco consumption of 10 or more packs/year were recruited at two university hospitals. FS (gold standard) was performed and FEV1, FVC, and FEV1/FVC measurements were compared with FEV1, FEV6, and FEV1/FEV6 measurements acquired using Piko-6® and COPD-6® devices. The devices were compared using statistical methods including Pearson correlation coefficients, the Youden index (YI), kappa coefficient, Bland-Altman plots, and ROC curves analysis. Results: Correlations between FEV1/FEV6 using Piko-6® and COPD-6® and FEV1/FVC with FS were 0.79 and 0.73, respectively. Piko-6® achieved the best YI in FEV1/FEV6 (0.73), whereas for COPD-6®, it was 0.80. Concordance between Piko-6® and FS was 83.9% (kappa 0.67 ± 0.028) and for COPD-6®, it was 68.7% (kappa 0.42 ± 0.02). Conclusions: This is the first study that compares two hand-held expiratory flow meters with FS. Piko-6® and COPD-6® devices are effective tools for COPD detection, as their measurements provide a good correlation with FS. In order to avoid false negative results, the FEV1/FEV6 cutoff point needs to be increased to 0.73 and 0.80 with Piko-6® and COPD-6®, respectively.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

